Platinum-Based Chemotherapy and Immunotherapy in Early Triple-Negative Breast Cancer: A Meta-Analysis and Indirect Treatment Comparison

BACKGROUND: Triple-negative breast cancer (TNBC) comprises 15% of invasive breast cancers. Platinum-based chemotherapy and immune checkpoint inhibitors (ICIs) have been extensively researched in recent years as promising treatments in the neoadjuvant setting. However, clinical data is lacking in dir...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Qin, Peng, Yicheng, Sun, Jie, Liu, Jianxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281677/
https://www.ncbi.nlm.nih.gov/pubmed/34277438
http://dx.doi.org/10.3389/fonc.2021.693542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281677/
https://www.ncbi.nlm.nih.gov/pubmed/34277438
http://dx.doi.org/10.3389/fonc.2021.693542

Ejemplares similares